Neelam Shahani

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Embryonic Stem Cells

Signaling Pathway

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Uri Nimrod Ramírez-Jarquín, Manish Sharma, Wuyue Zhou, Neelam Shahani, Srinivasa Subramaniam
Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 119 (5) (2022)
Uri Nimrod Ramírez-Jarquín, Srinivasa Subramaniam, Neelam Shahani, Yuquing Li, Siddaraju V Boregowda, Srinivasa Subramaniam
Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain. Science advances 8 (12) (2022)
Taneli Heikkinen, Timo Bragge, Juha Kuosmanen, Teija Parkkari, Sanna Gustafsson, Mei Kwan, Jose Beltran, Afshin Ghavami, Srinivasa Subramaniam, Neelam Shahani, Uri Nimrod Ramírez-Jarquín, Larry Park, Ignacio Muñoz-Sanjuán, Deanna M Marchionini
Global Rhes knockout in the Q175 Huntington's disease mouse model. PloS one 16 (10) (2021)
Mehdi Eshraghi, Pabalu P Karunadharma, Juliana Blin, Neelam Shahani, Emiliano P Ricci, Audrey Michel, Nicolai T Urban, Nicole Galli, Manish Sharma, Uri Nimrod Ramírez-Jarquín, Katie Florescu, Jennifer Hernandez, Srinivasa Subramaniam
Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. Nature communications 12 (1) (2021)
Manish Sharma, Sumitha Rajendrarao, Neelam Shahani, Uri Nimrod Ramírez-Jarquín, Srinivasa Subramaniam
Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 117 (27) (2020)
Mehdi Eshraghi, Uri Nimrod Ramírez-Jarquín, Neelam Shahani, Tommaso Nuzzo, Arianna De Rosa, Supriya Swarnkar, Nicole Galli, Oscar Rivera, George Tsaprailis, Catherina Scharager-Tapia, Gogce Crynen, Qin Li, Marie-Laure Thiolat, Erwan Bezard, Alessandro Usiello, Srinivasa Subramaniam
RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. Science advances 6 (18) (2020)